Markets›Health care›JNJ

Johnson & Johnson

JNJ
271.22
+0.54 (+0.20%)
Closing price for Sep 25, 2026 from Polygon.io
Income statement Balance sheet Cash flow | Annual Quarterly |Download CSV
Balance sheet (USD) FY 2025
ended Dec 28, 2025
FY 2024
ended Dec 29, 2024
FY 2023
ended Dec 31, 2023
FY 2022
ended Jan 1, 2023
FY 2021
ended Jan 2, 2022
FY 2020
ended Jan 3, 2021
Cash and equivalents 19.71B24.11B21.86B12.89B14.49B13.98B
Short-term investments 393.00M417.00M1.07B9.39B17.12B11.20B
Receivables 17.18B14.84B14.87B14.04B15.28B13.58B
Inventory 14.19B12.44B11.18B10.27B10.39B9.34B
Total current assets 55.62B55.89B53.49B55.29B60.98B51.24B
Property, plant and equipment 23.17B20.52B19.90B17.98B18.96B18.77B
Goodwill and intangibles 99.17B81.82B70.73B74.54B71.83B89.80B
Total assets 199.21B180.10B167.56B187.38B182.02B174.89B
Accounts payable 11.99B10.31B9.63B9.89B11.05B9.51B
Total current liabilities 54.13B50.32B46.28B55.80B45.23B42.49B
Long-term debt 39.44B30.65B25.88B26.89B29.98B32.63B
Total liabilities 117.67B108.61B98.78B110.57B108.00B111.62B
Retained earnings 168.98B155.79B153.84B128.34B123.06B113.89B
Shareholders' equity 81.54B71.49B68.77B76.80B74.02B63.28B
Total debt 56.43B42.63B32.83B52.44B37.55B37.87B
Net debt 36.72B18.53B10.97B39.55B23.06B23.88B

From Johnson & Johnson's 10-K and 10-Q filings with the SEC. Fiscal years are the company's own, so they may not match the calendar. A blank cell means the company did not report that line. New to this? Read balance sheet or reading a 10-K.

Charts

Revenue, earnings, margins and balance sheet trends drawn by TradingView from its own data, so figures can differ slightly from the SEC table above.